docetaxel anhydrous has been researched along with Delayed Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacakoglu, F; Cok, G; Erdinc, M; Goker, E; Goksel, O; Goksel, T; Karakus, H; Uslu, R | 1 |
| Fu, B; Li, Y; Liu, WP; Wang, GX; Xi, HB | 1 |
1 trial(s) available for docetaxel anhydrous and Delayed Hypersensitivity
| Article | Year |
|---|---|
Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Agents; Cancer Vaccines; Dendritic Cells; Docetaxel; Humans; Hypersensitivity, Delayed; Inhibitor of Apoptosis Proteins; Male; Middle Aged; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Survivin; Taxoids; Vaccination | 2015 |
1 other study(ies) available for docetaxel anhydrous and Delayed Hypersensitivity
| Article | Year |
|---|---|
Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cross-Sectional Studies; Desensitization, Immunologic; Docetaxel; Drug Eruptions; Etoposide; Female; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Skin Tests; Taxoids | 2015 |